Cover Image for Synbio & AI Breakfast
Cover Image for Synbio & AI Breakfast
Avatar for Exapto
Presented by
Exapto

Synbio & AI Breakfast

Register to See Address
Registration
Approval Required
Your registration is subject to host approval.
Welcome! To join the event, please register below.
About Event

​The Golden Age of Biomanufacturing: What Will the Chemical Industry Actually Pay For ?

​The first synbio wave proved the science and the technology. The second is being built differently, starting from industrial production, with AI embedded from day one. Inspired by the semiconductor industry, Exapto and Arsenale Bioyards, two companies redesigning complementary steps of the biomanufacturing value chain, open with real business cases from the field. Over breakfast with Serena and Planet A, join a partner-level roundtable on where validated demand already exists, where value concentrates, and which European companies can win.

​Event details

​🥐 8:30-10:00 30min roundtable with co-founders Olivier Rolland (Exapto) and Arnaud Lergis (Arsenale) & networking breakfast

​Location : shared upon registering


​Exapto is building the ARM and Arsenale the TSMC* of biomanufacturing to power its new era.

​Exapto is a synthetic biology R&D company dedicated to the chemical industry. Nature runs a limited set of chemical reactions. Instead of optimizing what it already does, Exapto identifies chemical functions Nature can perform but currently does not (e.g. latent chemical reactions, alternative use of cellular machinery) and repurposes living systems to run them at industrial scale. Exapto provides industrial manufacturers biodesigns and biocomponents to improve existing processes as well as to produce, from renewable carbon, molecules previously out of biological reach.

​Arsenale Bioyards is building Industrial Biological AI: the intelligence layer that makes industrial biology scalable, and the factory it learns from. Biology cannot be simulated, so the data has to be produced. Arsenale produces it in bioreactors built to read the biology itself, under industrial conditions, run after run, with intelligence, hardware, and production data designed as one system. A company brings a molecule. Arsenale designs the entire production process around it, from fermentation to purification, predicts its cost at industrial scale, and validates it in steel on its own production equipment. Arsenale sells its clients three things: a qualified process, the kilograms it produces at a known cost, and what every run has taught. The learning compounds, and the intelligence improves with every molecule it produces. In 1987, TSMC separated chip design from production. Arsenale is now doing the same for biology.


​About

​Planet A is an early-stage European tech VC backing founders solving the world’s greatest challenges. We take a scientific approach to identify breakthrough technologies across energy, bio-economy, manufacturing and critical infrastructure.

​Serena is a pan-European fund, with $1.2B in AUM, investing 1M€ to 15M€ tickets from pre-seed to Series B across deeptech, energy, climate, and health.


​*In semiconductors, ARM designs chips and licenses the IP, while TSMC manufactures them at scale for its clients.

Location
Please register to see the exact location of this event.
Avatar for Exapto
Presented by
Exapto